Funding

Infinitopes

United Kingdom · Biotech

Develops precision therapeutic vaccines against multiple solid tumour indications

Visit infinitopes.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Seed$15.4MAmplify Bio — Role not disclosedCancer Research Horizons — Role not disclosedMacmillan Cancer Support — Role not disclosedManta Ray Ventures — Role not disclosedOctopus Ventures — Role not disclosed

Investors

Amplify BioSeedCancer Research HorizonsSeedMacmillan Cancer SupportSeedManta Ray VenturesSeedOctopus VenturesSeed

Coverage

Jan 21, 2026Infinitopes · Seed

Similar companies

Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200M · Private financing
iCUREXKagoshima medical-device company developing chitosan hydrogel materials for wound care, including the syringe-delivered Kitosla CX dressing.¥140M · Series A first close: equity and debt
Sourcesinfinitopes.com ↗